Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome

Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome

Aim: to study plasmapheresis (PP) effect on antiphospholipid syndrome (APS) treatment during preconception preparation and pregnancy.Materials and Methods. A single-center, prospective, randomized, uncontrolled study was conducted. A total of 137 women aged 22 to 32 years diagnosed with APS-related...

Full description

Saved in:
Bibliographic Details
Main Authors: N. F. Kuneshko, V. V. Kim, E. M. Lyadnova, A. R. Metkina, M. N. Velieva, A. V. Lazarchuk, V. O. Bitsadze, M. V. Tretyakova, D. V. Blinov
Format: Article
Language:Russian
Published: IRBIS LLC 2025-03-01
Series:Акушерство, гинекология и репродукция
Subjects:
obstetric antiphospholipid syndrome
aps
plasmapheresis
pр
lupus anticoagulant
la
anti-cardiolipin antibodies
acl
anti-β2-glycoprotein 1 antibodies
anti-β2-gр1
anti-annexin v antibodies
anti-anx
placenta-associated complications
Online Access:https://www.gynecology.su/jour/article/view/2346
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.gynecology.su/jour/article/view/2346

Similar Items